We are live on
!
Find out more
OAG
Orbis Allan Gray Portfolio holdings
AUM
$23.7B
1-Year Est. Return
65.43%
This Fund
S&P 500
This Quarter
Est. Return
+0.33%
1 Year Est. Return
+65.43%
3 Year Est. Return
+132.45%
5 Year Est. Return
+177.59%
10 Year Est. Return
+818.17%
AUM
$13.9B
AUM Growth
-$853M
(-5.8%)
Cap. Flow
-$759M
Cap. Flow
% of AUM
-5.47%
Top 10 Holdings %
Top 10 Hldgs %
70.08%
Holding
61
New
4
Increased
19
Reduced
26
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$187M |
| 2 |
S&P Global
SPGI
|
+$151M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$145M |
| 4 |
BERY
Berry Global Group, Inc.
BERY
|
+$141M |
| 5 |
British American Tobacco
BTI
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$423M |
| 2 |
SLB Ltd
SLB
|
+$211M |
| 3 |
Howmet Aerospace
HWM
|
+$185M |
| 4 |
Wells Fargo
WFC
|
+$122M |
| 5 |
Dollar General
DG
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 35.13% |
| 2 | Healthcare | 21.81% |
| 3 | Industrials | 11.31% |
| 4 | Energy | 9.11% |
| 5 | Financials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
NetEase
NTES
$76.9B
| $2.65B | 19.06% |
51,753,700
-1,143,670
| -2% | -$60.7M |
|
2
AbbVie
ABBV
$454B
| $1.25B | 8.99% |
17,168,153
-642,029
| -4% | -$50.5M |
|
3
XPO
XPO
$25.1B
| $1.24B | 8.92% |
61,943,302
-4,583
| -0% | -$93.3K |
|
4
Autohome
ATHM
$2.45B
| $892M | 6.42% |
10,413,781
+619,359
| +6% | +$61.7M |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $873M | 6.28% |
9,444,476
-4,452,234
| -32% | -$423M |
|
6
Meta Platforms (Facebook)
META
$1.54T
| $754M | 5.43% |
3,906,412
-553,353
| -12% | -$101M |
|
7
Elevance Health
ELV
$82.3B
| $601M | 4.33% |
2,131,295
+175,707
| +9% | +$48M |
|
|
8
Alphabet (Google) Class C
GOOG
$3.89T
| $545M | 3.92% |
10,083,620
+2,508,800
| +33% | +$145M |
|
9
Vale
VALE
$63.1B
| $473M | 3.4% |
35,192,054
-7,624,347
| -18% | -$97.8M |
|
|
10
S&P Global
SPGI
$124B
| $464M | 3.34% |
2,035,811
+693,459
| +52% | +$151M |
|
|
11
Dollar General
DG
$25.4B
| $417M | 3% |
3,085,883
-817,942
| -21% | -$103M |
|
12
APA Corp
APA
$12.9B
| $380M | 2.73% |
13,114,954
-1,378,409
| -10% | -$42.9M |
|
|
BERY
13
DELISTED
Berry Global Group, Inc.
BERY
| $341M | 2.45% |
7,061,014
+2,920,782
| +71% | +$141M |
|
|
14
Howmet Aerospace
HWM
$115B
| $317M | 2.28% |
15,988,176
-10,935,580
| -41% | -$185M |
|
15
Itaú Unibanco
ITUB
$92B
| $306M | 2.21% |
44,691,772
+10,289,127
| +30% | +$64.8M |
|
|
16
UnitedHealth
UNH
$385B
| $305M | 2.19% |
1,247,903
+777,973
| +166% | +$187M |
|
|
17
Wells Fargo
WFC
$261B
| $234M | 1.69% |
4,949,238
-2,604,832
| -34% | -$122M |
|
18
TSMC
TSM
$2.16T
| $222M | 1.59% |
5,656,251
-595,119
| -10% | -$24.5M |
|
19
SPDR Gold Trust
GLD
$130B
| $215M | 1.55% |
1,613,839
+15,047
| +0.9% | +$1.86M |
|
20
Golar LNG
GLNG
$5.07B
| $190M | 1.37% |
10,307,287
+1,019,343
| +11% | +$19.4M |
|
|
21
SLB Ltd
SLB
$70.6B
| $181M | 1.31% |
4,563,527
-5,243,819
| -53% | -$211M |
|
|
RDS.B
22
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $158M | 1.13% |
2,397,537
+40,235
| +2% | +$2.62M |
|
23
Alcoa
AA
$11.9B
| $140M | 1.01% |
5,969,162
+1,200,786
| +25% | +$29.9M |
|
|
24
British American Tobacco
BTI
$129B
| $138M | 0.99% |
3,952,316
+3,536,810
| +851% | +$134M |
|
25
Peabody Energy
BTU
$2.9B
| $117M | 0.84% |
4,842,102
-2,646,761
| -35% | -$69.6M |
|
Similar funds
CHP
SAM
JG
Orbis Allan Gray's Q2 2019 Portfolio in Review
As of Q2 2019, Orbis Allan Gray held 61 positions worth $13.9B, down 5.8% from $14.7B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Orbis Allan Gray withdrew a net $759M in Q2 2019, closing 4 positions and reducing 26 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $31.3M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 35% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Orbis Allan Gray opened a new position in Alibaba worth $6.24M.
- Orbis Allan Gray's largest Q2 2019 buy was Alibaba: 36,847 shares worth $6.24M.
- Orbis Allan Gray added most to UnitedHealth in Q2 2019, an estimated $187M increase.
- Orbis Allan Gray's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $423M.
- Orbis Allan Gray fully exited Bristol-Myers Squibb in Q2 2019, selling an estimated $31.3M.
- Orbis Allan Gray's ten largest holdings make up 70% of its $13.9B portfolio in Q2 2019.
- Orbis Allan Gray opened 4 new positions and closed 4 in Q2 2019.
- Orbis Allan Gray's portfolio value fell 5.8% quarter-over-quarter to $13.9B.
Based on Orbis Allan Gray's 13F filing for Q2 2019, filed 14 Aug 2019.